Individual Placement and Support for Patients With Offending Histories (IPSOH)

February 9, 2018 updated by: Najat Khalifa, Nottinghamshire Healthcare NHS Trust

Individual Placement and Support (IPS) for Patients With Offending Histories: Feasibility of an Evidence-based Approach in Forensic Mental Health Settings

The overall aim of the study is to assess the feasibility of conducting a Randomized Controlled Trial (RCT) to evaluate the effectiveness of Individual Placement and Support (IPS) in improving employment rates and associated psychosocial outcomes in forensic psychiatric populations.

Study Overview

Status

Terminated

Detailed Description

This is a feasibility trial which aims to assess the feasibility of conducting a full Randomized Controlled Trial (RCT) to evaluate the effectiveness of Individual Placement and Support (IPS) in improving employment rates and associated psychosocial outcomes in forensic psychiatric populations.

Given that IPS is a complex intervention, the design of this study has drawn from the principles set out in the UK Medical Research Council (MRC) Guidance on developing and evaluating complex interventions by defining three major research strands in order to achieve the specific objectives of the study as follows:

A. Implementation of IPS in community forensic services: The specific objective of this strand is to embed the IPS model in the community forensic services in which the feasibility study will be carried out (aided by an IPS Expert), by bringing an employment specialist into clinical teams, raising awareness about IPS within the organization, forming links with IPS services in the area and developing links with employers, as well as conducting IPS fidelity reviews.

B. Feasibility Cluster Randomized Controlled Trial (RCT): The specific objectives of this strand are to estimate the parameters required to design a full RCT including:

  1. Means and standard deviations of the key outcome measures in order to benchmark potential effect sizes and enable sample size calculations.
  2. The feasibility of randomization, recruitment and retention rates to the IPS and controls;
  3. The suitability of the key outcome measures with respect to: reliability, acceptability, and distribution of the scores.

C. Process Evaluation: This will be carried out in parallel with the other two strands to meet other specific objectives by using the following methods:

  1. Qualitative interviews with staff to identify the structural, legal, organizational and individual-level to barriers and facilitators to implementation of IPS in community forensic services.
  2. Fidelity Reviews to assess the extent to which the services follow the principles of IPS and to assess how well the employment specialist functions within the community forensic services.
  3. Qualitative interviews with patients assigned to IPS in order to assess their general views of IPS, benefits from participating, disadvantages from or dislikes about participating and barriers and facilitators to implementation.

Study Type

Interventional

Enrollment (Actual)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nottingham, United Kingdom
        • Nottinghamshire NHS Foundation Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adults over the age of 18 years
  • Patients (females and males) on the caseload of the community forensic services

Exclusion Criteria:

  • Patients unable to provide informed consent
  • Patients not eligible to work in the UK
  • Patients currently in open employment
  • Patients who do not wish to work

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Individual Placement and Support
Individual Placement and Support is a form of supported employment.
No Intervention: Treatment as Usual
Treatment as Usual is comprised of routine clinical care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Open Employment: Proportion of people in open employment
Time Frame: 12 Months
Proportion of people in open employment at 12 month follow-up
12 Months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of hours worked
Time Frame: 12 Months
Number of hours worked at 12 month follow-up
12 Months
Mental health as measured using the Brief Psychiatric Rating Scale (BPRS)
Time Frame: Baseline, 6 and 12 Months
Measured using the Brief Psychiatric Rating Scale (BPRS)
Baseline, 6 and 12 Months
Social Functioning as measured using the Social Functioning Questionnaire (SFQ)
Time Frame: Baseline, 6 and 12 Months
Measured using the Social Functioning Questionnaire (SFQ)
Baseline, 6 and 12 Months
Self-Esteem as measured using the Rosenberg's Self Esteem Scale
Time Frame: Baseline, 6 and 12 Months
Measured using the Rosenberg's Self Esteem Scale
Baseline, 6 and 12 Months
Work Limitations as measured using the Work Limitation Questionnaire
Time Frame: Baseline, 6 and 12 Months
Measured using the Work Limitation Questionnaire
Baseline, 6 and 12 Months
Quality of life as measured using SF-12v2
Time Frame: Baseline, 6 and 12 Months
Health-related quality of life as measured using SF-12v2
Baseline, 6 and 12 Months
Economic Costing as measured using the Client Service Receipt Inventory (CSRI)
Time Frame: Baseline, 6 and 12 Months
Measured using the Client Service Receipt Inventory (CSRI)
Baseline, 6 and 12 Months
Re-offending rates
Time Frame: Baseline and 18 Months
Re-offending rates
Baseline and 18 Months
Number of days in open employment
Time Frame: 12 months
Number of days in open employment at 12 months
12 months
Quality of life as measured using the EQ5-D
Time Frame: Baseline, 6 and 12 months
Health-related quality of life as measured using the EQ5-D
Baseline, 6 and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Najat R Khalifa, DM, Nottinghamshire Healthcare Nhs Trust

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2015

Primary Completion (Actual)

September 15, 2017

Study Completion (Actual)

November 3, 2017

Study Registration Dates

First Submitted

May 7, 2015

First Submitted That Met QC Criteria

May 8, 2015

First Posted (Estimate)

May 13, 2015

Study Record Updates

Last Update Posted (Actual)

February 12, 2018

Last Update Submitted That Met QC Criteria

February 9, 2018

Last Verified

February 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • KHALIFA/020415
  • PB-PG-1013-32093 (Other Grant/Funding Number: NIHR - Research for Patient Benefit (RfPB))

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Treatment as Usual

Clinical Trials on Individual Placement and Support

3
Subscribe